Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Sarfati

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Journal of Clinical Epidemiology|June 29, 2012
Review of methods used to measure comorbidity in cancer populations: no gold standard existsDiana Sarfati
The Lancet. Oncology|October 19, 2015
Equitable cancer control: better data needed for indigenous peopleDiana Sarfati, Bridget Robson
The New Zealand Medical Journal|July 7, 2014
Response to Richardson and Potter's "Screening for colorectal cancer and prostate cancer: challenges for New Zealand"--with authors' replyDiana Sarfati, Ian Bissett
BMJ (Clinical Research Ed.)|March 16, 2018
Cancer inequalities endure despite NHS reformsDiana Sarfati, Christopher Jackson
Lancet (London, England)|August 21, 2022
Preventing cancer: the only way forwardDiana Sarfati, Jason Gurney
Journal of Clinical Epidemiology|August 29, 2017
The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general populationJames Stanley, Diana Sarfati
The New Zealand Medical Journal|September 29, 2011
Improvement in the accuracy of hospital ethnicity dataJuliet Rumball-Smith, Diana Sarfati
The New Zealand Medical Journal|January 17, 2013
Readmission: use with cautionJuliet Rumball-Smith, Diana Sarfati
The New Zealand Medical Journal|December 16, 2016
How 'modifiable' are 'modifiable risk factors' for cancer?Christopher Gca Jackson, Diana Sarfati
The New Zealand Medical Journal|March 26, 2021
Modelling: one tool in the decision-making toolkitDiana Sarfati, Nisha Nair, Michelle Mako
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical Epidemiology|June 29, 2012
Review of methods used to measure comorbidity in cancer populations: no gold standard existsDiana Sarfati
The Lancet. Oncology|October 19, 2015
Equitable cancer control: better data needed for indigenous peopleDiana Sarfati, Bridget Robson
The New Zealand Medical Journal|July 7, 2014
Response to Richardson and Potter's "Screening for colorectal cancer and prostate cancer: challenges for New Zealand"--with authors' replyDiana Sarfati, Ian Bissett
BMJ (Clinical Research Ed.)|March 16, 2018
Cancer inequalities endure despite NHS reformsDiana Sarfati, Christopher Jackson
Lancet (London, England)|August 21, 2022
Preventing cancer: the only way forwardDiana Sarfati, Jason Gurney
Journal of Clinical Epidemiology|August 29, 2017
The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general populationJames Stanley, Diana Sarfati
The New Zealand Medical Journal|September 29, 2011
Improvement in the accuracy of hospital ethnicity dataJuliet Rumball-Smith, Diana Sarfati
The New Zealand Medical Journal|January 17, 2013
Readmission: use with cautionJuliet Rumball-Smith, Diana Sarfati
The New Zealand Medical Journal|December 16, 2016
How 'modifiable' are 'modifiable risk factors' for cancer?Christopher Gca Jackson, Diana Sarfati
The New Zealand Medical Journal|March 26, 2021
Modelling: one tool in the decision-making toolkitDiana Sarfati, Nisha Nair, Michelle Mako
Pageof 16